Company Filing History:
Years Active: 2016-2018
Title: Yannick Nizet: Innovator in Antibody Production
Introduction
Yannick Nizet is a notable inventor based in Lincent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of antibody production. With a total of 2 patents to his name, Nizet's work is paving the way for advancements in medical research and therapeutic applications.
Latest Patents
Nizet's latest patents focus on a method for producing antibodies using a 'naked' expression vector that expresses a type II transmembrane fusion protein. The methods disclosed in these patents detail how to generate antibodies and the expression vector used to express proteins that provoke an antibody response. The expression vector is designed to generate an antibody directed to an antigen, comprising a gene in operable linkage with a promoter. This gene encodes a fusion protein that includes CD134L as the N-terminal moiety and an antigenic protein as the C-terminal moiety. By injecting this vector into a subject animal, a fusion protein is produced, which subsequently generates antibodies.
Career Highlights
Yannick Nizet is currently associated with Delphi Genetics S.A., where he continues to innovate in the field of biotechnology. His work is instrumental in developing new methods for antibody generation, which can have far-reaching implications in therapeutic treatments.
Collaborations
Nizet collaborates with esteemed colleagues such as Jean-Christophe Renauld and Muriel Lemaire. Their combined expertise enhances the research and development efforts at Delphi Genetics S.A.
Conclusion
Yannick Nizet's contributions to antibody production through innovative methods are noteworthy. His patents reflect a commitment to advancing biotechnology and improving therapeutic options.